Cargando…
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer
The Prostate Specific Antigen (PSA) test suffers from low specificity for the diagnosis of Prostate Cancer (PCa). We originally discovered two cancer-related proteins thrombospondin-1 (THBS1) and cathepsin D (CTSD) using a mass-spectrometry-based proteomics approach. The two serum proteins were show...
Autores principales: | Macagno, Annalisa, Athanasiou, Alcibiade, Wittig, Anja, Huber, Ramy, Weber, Stephan, Keller, Thomas, Rhiel, Martin, Golding, Bruno, Schiess, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233579/ https://www.ncbi.nlm.nih.gov/pubmed/32421745 http://dx.doi.org/10.1371/journal.pone.0233442 |
Ejemplares similares
-
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018) -
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology
por: Athanasiou, Alcibiade, et al.
Publicado: (2021) -
Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel
por: Humisto, Anu, et al.
Publicado: (2023) -
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
por: Endt, Kathrin, et al.
Publicado: (2017) -
The IVD Directive and Availability of Reference Systems for IVD Medical Devices: A View from Industry
por: Greenberg, Neil
Publicado: (2001)